BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27769307)

  • 1. Effects of financial support on treatment of adolescents with growth hormone deficiency: a retrospective study in Japan.
    Maeda E; Higashi T; Hasegawa T; Yokoya S; Mochizuki T; Ishii T; Ito J; Kanzaki S; Shimatsu A; Takano K; Tajima T; Tanaka H; Tanahashi Y; Teramoto A; Nagai T; Hanew K; Horikawa R; Yorifuji T; Wada N; Tanaka T
    BMC Health Serv Res; 2016 Oct; 16(1):602. PubMed ID: 27769307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
    Isojima T; Hasegawa T; Yokoya S; Tanaka T
    Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T; Basiak A; Zubkiewicz-Kucharska A; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):39-43. PubMed ID: 20529605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed growth due to growth hormone deficiency (study of 16 cases)].
    Hachicha M; Kammoun T; Kolsi S; Mahfoudh A; Jardak N; Aloulou H; Bouaziz N; Triki A
    Tunis Med; 2002 Jun; 80(6):317-23. PubMed ID: 12534042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender bias in children receiving growth hormone treatment.
    Hughes IP; Choong CS; Cotterill A; Harris M; Davies PS
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1191-8. PubMed ID: 20080858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
    Hardin DS; Woo J; Butsch R; Huett B
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
    Kawai M; Momoi T; Mamada M; Yorifuji T; Nakahata T
    Clin Endocrinol (Oxf); 2004 May; 60(5):608-12. PubMed ID: 15104564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.
    Yordam N; Kandemir N; Alikaşifoğlu A
    Turk J Pediatr; 1998; 40(1):55-60. PubMed ID: 9673529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.